Latest Articles
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - Physician's Weekly
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers Physician's Weekly
Published: Nov. 30, 2024, 10:44 a.m.
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - 2 Minute Medicine
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers 2 Minute Medicine
Published: Nov. 30, 2024, 12:15 a.m.
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens - OncLive
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens OncLive
Published: Nov. 5, 2024, 3:07 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com
Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com
Published: Oct. 24, 2024, 10:45 a.m.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com
Published: April 23, 2024, 7 a.m.
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor
Published: March 17, 2024, 7 a.m.
Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham
Gynecologic cancers: Early detection and understanding symptoms can save lives University of Alabama at Birmingham
Published: Jan. 26, 2024, 8 a.m.
SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report.
Clear cell carcinomas are rare and relatively chemo-insensitive ovarian cancers with a characteristic molecular pathogenesis. Alterations in ARID1A, a component of the multiprotein chromatin remodeling complex SWI/SNF, are likely early …
Published: Nov. 14, 2023, midnight
Expression of small heat shock proteins in exosomes from patients with gynecologic cancers.
Small Heat shock proteins (sHsp) are a group of chaperone proteins. Under conditions of stress, the expression of sHsp is increased. Therefore, they are implicated in the pathogenesis of various …
Published: July 8, 2019, midnight
Link copied to clipboard!